Related Experiment Video
Updated: Sep 17, 2025
12:24
Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
10.0K
Myocarditis Following COVID-19 Vaccine: What Did We Learn?
Joseph Abourjeili1, Christelle Lattouf1, Anthony Abou Mrad1
1American University of Beirut Medical Center, Beirut, Lebanon.
Sage Open Pediatrics
|July 4, 2025
Summary
Myocarditis after mRNA COVID-19 vaccination is rare, primarily affecting young males within days of the second dose. Most cases are mild and resolve with treatment, confirming vaccine safety.
Area of Science:
- Immunology
- Cardiology
- Public Health
Background:
- The COVID-19 pandemic necessitated rapid vaccine development.
- mRNA COVID-19 vaccines are crucial for global control.
- Concerns exist regarding potential cardiovascular adverse events, specifically myocarditis.
Purpose of the Study:
- To review and analyze the incidence and characteristics of myocarditis following mRNA COVID-19 vaccination.
- To evaluate the risk-benefit profile of mRNA COVID-19 vaccines concerning myocarditis.
Main Methods:
- Systematic review and analysis of over 40 studies.
- Examination of reported cases of myocarditis post-mRNA COVID-19 vaccination.
- No clinical trials were conducted for this review.
Main Results:
- Myocarditis incidence is highest within 2-4 days after the second mRNA COVID-19 vaccine dose.
- Affected individuals are predominantly males aged 12-39 years.
- Symptoms like chest pain and dyspnea are typically mild and respond to supportive care.
Conclusions:
- The risk of myocarditis following mRNA COVID-19 vaccination is low.
- Proposed mechanisms include molecular mimicry and hypersensitivity.
- The benefits of COVID-19 vaccination significantly outweigh the risks.
Related Concept Videos
01:14Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
01:27Myocarditis II: Clinical Features and Diagnostic Tests
31
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
31
01:21Myocarditis I: Introduction
35
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
35
01:22Myocarditis IV: Nursing Management
36
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
36
01:22Pericarditis I: Introduction
26
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
26
01:17Pericarditis III: Medical Management
28
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
28